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Abstract: Background: Electrical current can be used to stimulate upper airway dilator muscles to treat
obstructive sleep apnoea (OSA). Ultrasound devices are widely available and may be used to detect
contraction of the upper airway dilator muscles assessing the functionality of electrical stimulation (ES)
used for this treatment. Methods: In a physiological sub-study of a randomised controlled trial, patients
with OSA underwent ultrasound examination to assess contraction of the upper airway dilator muscles in
response to transcutaneous ES. Ultrasound scans were scored according to the picture quality (poor = ‘0’,
acceptable = ‘1’ and good = ‘2’). Tongue base thickness was assessed in mid-sagittal and coronal planes
with (D2, A2) and without ES (D1, A1), while awake and seated. The primary outcome was to determine
the increase in tongue thickness during ES in both views (D2 – D1 = ΔD), as well as any increase in
the cross-sectional area (CSA) in the coronal view (A2 – A1 = ΔA). Data were presented as mean and
standard deviation (SD). Results: Fourteen patients [eight male, age 57.5 (9.8) years, body mass index
(BMI) 29.5 (2.8) kg/m2] with OSA [Apnea-Hypopnea Index (AHI) 19.5 (10.6) × hour-1] were studied.
Quality of the ultrasound scans was acceptable or good with 1.5 (0.5) points. In the mid-sagittal plane,
ΔD was +0.17 (0.07) cm in midline and +0.21 (0.09) cm in the widest diameter, a percentual change
of 12.2% (4%) and 12.8% (5.2%) (P<0.001, respectively). In the coronal plane, ΔD was +0.17 (0.04)
cm, an increase of 12.3% (4.6%) (P<0.001, respectively), ΔA in the CSA increased by +18.9% (3.0%)
with stimulation (P<0.001). There was a negative correlation between age and ΔA (r= –0.6, P=0.03),
but no significant associations were found with gender, BMI, neck circumference, Epworth Sleepiness
Scale (ESS), AHI, skin and subcutaneous tissue in the submental area. Conclusions: Ultrasound can
visualise upper airway dilator muscle contraction during transcutaneous ES in awake patients with OSA.
Contraction is best detected in the CSA of the tongue base in the coronal plane. Keywords: Tongue;
genioglossus; geniohyoid; ultrasonographic; sonography; upper airway
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Background: Electrical current can be used to stimulate upper airway dilator muscles to treat obstructive 
sleep apnoea (OSA). Ultrasound devices are widely available and may be used to detect contraction of the 
upper airway dilator muscles assessing the functionality of electrical stimulation (ES) used for this treatment.
Methods: In a physiological sub-study of a randomised controlled trial, patients with OSA underwent 
ultrasound examination to assess contraction of the upper airway dilator muscles in response to 
transcutaneous ES. Ultrasound scans were scored according to the picture quality (poor = ‘0’, acceptable = 
‘1’ and good = ‘2’). Tongue base thickness was assessed in mid-sagittal and coronal planes with (D2, A2) and 
without ES (D1, A1), while awake and seated. The primary outcome was to determine the increase in tongue 
thickness during ES in both views (D2 – D1 = ΔD), as well as any increase in the cross-sectional area (CSA) 
in the coronal view (A2 – A1 = ΔA). Data were presented as mean and standard deviation (SD).
Results: Fourteen patients [eight male, age 57.5 (9.8) years, body mass index (BMI) 29.5 (2.8) kg/m2] 
with OSA [Apnea-Hypopnea Index (AHI) 19.5 (10.6) × hour-1] were studied. Quality of the ultrasound 
scans was acceptable or good with 1.5 (0.5) points. In the mid-sagittal plane, ΔD was +0.17 (0.07) cm in 
midline and +0.21 (0.09) cm in the widest diameter, a percentual change of 12.2% (4%) and 12.8% (5.2%) 
(P<0.001, respectively). In the coronal plane, ΔD was +0.17 (0.04) cm, an increase of 12.3% (4.6%) (P<0.001, 
respectively), ΔA in the CSA increased by +18.9% (3.0%) with stimulation (P<0.001). There was a negative 
correlation between age and ΔA (r= –0.6, P=0.03), but no significant associations were found with gender, 
BMI, neck circumference, Epworth Sleepiness Scale (ESS), AHI, skin and subcutaneous tissue in the 
submental area.
Conclusions: Ultrasound can visualise upper airway dilator muscle contraction during transcutaneous ES 
in awake patients with OSA. Contraction is best detected in the CSA of the tongue base in the coronal plane.
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Introduction
Obstructive sleep apnoea (OSA) is the most common 
form of sleep-disordered breathing (1,2). It represents 
a global health problem that causes daytime symptoms 
like sleepiness and affects the cardiovascular system (3,4). 
Symptomatic OSA affects up to 10% of middle-aged men 
and 3% of middle-aged women (1,2). Almost a quarter 
of the 30–69 year-old population in the UK may have 
mild OSA, while 4.8% of the same age range might have 
moderate to severe OSA (5). 
OSA is characterised by repeated episodes of partial or 
complete upper airway collapse that results in hypopnoeas 
or apnoeas while asleep and leads to intermittent hypoxia, 
frequent arousals and sleep fragmentation which causes 
daytime symptoms like excessive daytime sleepiness and 
impaired cognition (6). Several pathophysiological mechanisms 
such as upper airway anatomy and control, ventilatory control 
and arousal threshold contribute to OSA, and phenotypes can 
vary considerably between individuals (7,8). Obesity, male 
gender, age, alcohol and smoking are potential risk factors for 
OSA (9-12). Diminished upper airway dilator neuromuscular 
tone to maintain airway patency during sleep represents a 
major contributing factor (13,14).
Therapeutical recommendations for OSA include 
continuous positive airway pressure (CPAP),  oral appliances 
(mandibular advancement device, MAD) (15), positional 
therapy (16), behavioural interventions, such as lifestyle 
advice including weight loss, smoking cessation, and 
reduction of alcohol and sedatives use (17), bariatric surgery 
(18,19) and in a minority of selected cases upper airway 
surgery  or maxillomandibular advancement surgery (20,21).
CPAP therapy remains the first line therapy for OSA in 
most cases (22). It acts as a pneumatic splint and delivers 
pressurised air into the upper airway to maintain patency 
while asleep (17,23). It improves OSA associated symptoms, 
quality of life and reduces the clinical sequelae. However, 
long-term adherence to CPAP remains limited (24,25) and 
effective second line therapies are needed.
Electrical stimulation (ES) of the upper airway dilator 
muscles during sleep is a relatively novel approach to treat 
OSA. It targets the diminished neuromuscular tone of the 
upper airway dilator muscles, particularly the genioglossus 
muscle (GG), that promotes upper airway collapsibility 
(14,26,27). External activation of the dilator muscles can help 
to maintain airway patency while asleep with different methods 
employing this approach, invasively and non-invasively (28-31).
Hypoglossal nerve stimulation (HNS) is a unilateral 
method, approved by the United States Food and Drug 
Administration (FDA) in 2014 following publication of the 
STAR trial results (29). The National Institute for Health 
and Care Excellence (NICE) in the UK published its 
interventional procedure guidance on HNS in 2017 (32). 
In a follow up cohort study of patients with HNS it was 
shown that safety, treatment efficacy, improved sleepiness 
and quality of life were sustained over five years of use (33). 
Another  invas ive  approach i s  the  bi la tera l  HNS 
stimulation using the Genio™ system (Nyxoah SA, Mont-
Saint-Guibert, Belgium). It makes use of an implanted 
neurostimulator system that is activated by a battery-unit 
worn externally and effectively reduces OSA severity and 
improves quality of life (34).
As a non-invasive approach, transcutaneous ES in OSA 
(TESLA) was first introduced in 2011 (35). It is delivered 
via transcutaneous patches that apply low currents to the 
submental area throughout the night, stimulating the upper 
airway dilator muscle group without disturbing sleep (30,35). 
In a randomised sham-controlled crossover trial, patients 
significantly improved in the 4% oxygen desaturation index. 
Responders to the treatment were found to be slimmer, 
predominantly female and with mild-to-moderate OSA (30). 
This method is currently undergoing further assessment 
regarding usability, functionality and task accomplishment 
in clinical trials (36). A recent meta-analysis of HNS and 
transcutaneous ES concluded that there was a significant 
effect size, reducing the severity of OSA, when using ES (37).
Effective assessment of upper airway dilator muscle 
stimulation and contraction is required to identify potential 
responders to these methods. However, most methods to 
visualise the upper airway are cumbersome and require costly 
equipment (MRI) (38) and time (drug-induced sleep endoscopy, 
DISE) (39). In contrast, ultrasound is a non-invasive bedside 
device that is available in most hospitals. It can visualise the 
tongue in different planes and evaluate the contraction of the 
upper airway dilator muscles in response to ES (35,36,40).
In the current study, we sought to evaluate the use of 
ultrasound to demonstrate the contraction of upper airway 
dilator muscles using transcutaneous ES in patients with 
OSA while awake.
We present the following article in accordance with the 
STROBE checklist (available at http://dx.doi.org/10.21037/
jtd-cus-2020-001).
Methods
This was a physiological sub-study of a randomised 
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controlled trial (NCT03160456) at Guy’s and St Thomas’ 
NHS Foundation Trust in London, UK. The trial was 
conducted in accordance with the Declaration of Helsinki 
and the Harmonized Tripartite Guideline for Good 
Clinical Practice from the International Conference on 
Harmonization. The study included recruited patients from 
the Lane Fox Unit and the Sleep Disorders Centre between 
July 2018 until March 2019. Following approval by the 
research ethics committee (IRAS ID 217448), as well as the 
NHS Trust’s R&D department, eligible patients received the 
patient information sheet prior to discussions of eligibility; 
written and informed consent was obtained in all patients.
Objectives
The main outcome of interest of this sub-study was to 
determine the increase in tongue base diameters during 
transcutaneous ES (D2 ‒ D1 = ΔD) measured in mid-
sagittal and coronal planes, as well as the increase in the 
cross-sectional area (CSA) of the tongue base in the coronal 
view while ES was turned on and off (A2 ‒ A1 = ΔA). 
Secondary outcome parameters were to address the 
best planes and diameters showing muscle contraction 
during ES (delta and % of change), correlations between 
measurements in different planes (Pearson correlation 
analysis), establishing the most feasible method of tongue 
ultrasound examination in different scanning planes, and 
classification of the scanned ultrasound pictures based on 
quality and clarity of the targeted measurements (semi-
quantitative score, 0‒2 points).
Inclusion criteria
Patients with mild to mildly severe OSA who were 
diagnosed using overnight polysomnography with an 
Apnea-Hypopnea Index (AHI) >5/hour to <35/hour plus 
symptoms of sleepiness (ESS >10 points), who failed and/or 
had withdrawn from CPAP, with a body mass index (BMI) 
of 18.5‒32 kg/m2 were included.
Exclusion criteria
Exclusion criteria were based on our previous experience 
(TESLA trial) (30), the eligibility criteria of the STAR 
trial (29) and other trials that used HNS. A range of co-
morbidities made patients non-eligible for recruitment 
into the trial: non-respiratory sleep disorders, relevant 
respiratory and cardiovascular co-morbidities, facial hair 
affecting placement of the hydrogel patches, and known 
allergies to plasters or similar products.
Short protocol
Ultrasound was used to assess the functionality of 
transcutaneous electrical current to stimulate the upper 
airway dilator muscles by studying the change in tongue 
diameters in different scanning planes, in awake patients, 
seated, with and without the ES turned on. Each patient 
came for their assessment to Guy’s & St Thomas’ NHS 
Foundation Trust, the medical history was recorded, and a 
general physical examination took place, tongue ultrasound 
examination with and without transcutaneous ES, as well 
as a polysomnographic sleep study (Alice 6 equipment, 
Respironics, Murrysville, Pennsylvania, USA) were 
recorded to establish the patients’ AHI. 
Transcutaneous ES and ultrasound examination
The patients were awake and in seated posture with the 
head supported by the investigator’s non-dominant hand, 
and a relaxed and slightly opened mouth.
The skin in the patient’s submental area was wiped using 
alcohol pads. Then, two self-adhesive hydrogel skin patches 
(4×4 cm2; TENS company, Everway Medical Instruments 
Co Ltd) were placed in the submental area midway between 
the angle of the mandible and the chin, as previously 
described (30,35,36) (Figure 1).
The patches were connected via cables to a transcutaneous 
ES (TENS) machine (Premier Combo Plus, EM-6300A 
TENS/EMS, Everway Medical Instruments Co Ltd).
First, the machine remained switched OFF, skin patches 
were kept in place and the ultrasound scans were obtained 
(LOGIQTM, GE Healthcare, WI/USA).
GE 9L-RS superficial l inear probe (band width 
3.33–10 MHz, GE Healthcare, WI/USA) was used for 
imaging, in frequency 8–10 MHz, and 3.5–5 cm depth (the 
depth setting differs according to neck circumference as 
well as the tongue bulk). 
A generous amount of ultrasound gel was applied for 
better ultrasound transduction in the presence of the skin 
patches.
The transducer was positioned 2 cm from the chin in 
the mid-sagittal plane (Plane A), pointing cranially. Scans 
in this plane showed the skin, subcutaneous tissue and the 
thickness of tongue base muscles. The patient was then 
asked to move the tongue to confirm its’ visualization in the 
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real-time sonography. Repeated images were collected and 
saved for offline measurements and analysis (Figure 2).
In a next step, the probe was turned 90° pointing 
cranially to scan images in coronal view (Plane B). This 
view showed the skin, subcutaneous tissue, the two anterior 
bellies of digastric muscles, mylohyoid, geniohyoid and 
genioglossus muscles. Images in this plane were saved 
(Figure 3).
Ultrasound scans in both planes were performed again 
during transcutaneous ES. The electrical current was 
delivered at 30Hz and pulse duration of 250 µs. The current 
required to evoke a visible muscle contraction differed 
among patients. 
Positions of the probe for each scanning plane are kept 
unchanged. The distance between the upper margin of the 
geniohyoid muscle to the lower margin of the genioglossus 
muscle represents the tongue thickness. This distance with 
stimulation (D2) and without stimulation (D1) allowed to 
calculate the change in diameters (D2 ‒ D1 = ΔD). The 
increase in the CSA of the tongue in the coronal plane is 
represented as (A2 ‒ A1 = ΔA) (Figures 4,5).
Offline evaluation of the scans regarding picture quality 
using a semi-quantitative scale (0–2 points, Figure 6), with ‘0’ 
indicating poor and ‘2’ indicating the best quality:
 Poor quality score (‘0’), scans could not be clearly 
assessed due to blurred pictures, unadjusted and/
or uncentralised view, not showing the structures of 
interest, unadjusted depth.
 Acceptable quality score (‘1’), scans were of good 
average picture quality and resolution, but some of 
the structures were difficult to identify.
 Good quality score (‘2’), scans could clearly assess 
and record all structures and measurements in both 
planes, no blurring with distinct borders, good view, 
with stimulation on and off. 
Offline data analysis
At least four different pictures for each plane were recorded 
Figure 1 Frontal view showing the submental skin patches 
(4×4 cm2) placed in the submental area midway between angle of 
mandible and the chin.
Figure 2 Sagittal view. (A) the position of the transducer in the submental area (mid-sagittal plane), (B) ultrasound scan in the mid-sagittal 
plane with the following structures: skin (S), subcutaneous tissue (SC), mylohyoid (MH), geniohyoid (GH) and genioglossus (GG). The 
distance of the upper margin of GH to the lower margin of GG represents the tongue base thickness (white arrow).
A B
S143Journal of Thoracic Disease, Vol 12, Suppl 2 October 2020
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2020;12(Suppl 2):S139-S152 | http://dx.doi.org/10.21037/jtd-cus-2020-001
and assessed for quality (0–2 points), on and off stimulation, 
respectively. Each structure was measured at least three 
different times on each picture, the average of these 
measurements was recorded. The following measurements 
were taken:
(I) Mid-sagittal plane: the midline and the widest 
diameter of the tongue base thickness while 
stimulation was on compared to the off mode 
(ΔDsagittal; Figure 4B,C).
(II) Coronal plane: the tongue base thickness in the 
midline (ΔDcoronal; Figure 5B,C) as well as the CSA 
of the tongue, comparing on with off mode (ΔA) 
A B
Figure 3 Coronal view. (A) positioning of the transducer in the submental area (coronal plane), (B) ultrasound scan in the coronal plane 
showing the following structures: skin (S), subcutaneous tissue (SC), anterior bellies of digastric muscles bilaterally (D), mylohyoid 
(MH), geniohyoid (GH), genioglossus (GG) and sublingual glands (SLG) on both sides. The distance of the upper margin of the GH to 
the lower border of the GG represents the tongue base thickness (white arrow) and the surrounding (white outline) represent the cross-
sectional area (CSA).
Figure 4 The tongue diameters in mid-sagittal plane with and without stimulation. (A) Position of the probe in the mid-sagittal plane, (B) 
in OFF-mode, illustrating the measured distances (D1), (C) in ON-mode, illustrating the increased distances (D2); in (B) & (C) tongue 
base thickness is measured in the mid-line by the double-arrowed red line, and in the widest diameter by the double-arrowed yellow line, 
(D2 – D1 = ΔD).
A B C
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(Figure 5D,E). 
(III) Differences in diameters (Δ) were reported in 
centimeters (cm) and percentual change (%) from 
baseline, and in square centimeters (cm2) for 
the CSA. 
Statistical analysis
The analysis of the data was carried out using the IBM SPSS 
20.0 statistical package software (SPSS Inc., Chicago, IL, 
USA). Data were expressed as mean and standard deviation 
(SD) for quantitative parametric measures in addition to 
both number and percentage for categorized data. ANOVA 
test was used for comparison between different planes using 
a post-hoc analysis with Least Significance Difference 
(LSD) for multiple comparisons. Correlations between the 
parameters were analysed reporting the Pearson correlation 
analysis. A P value of 0.05 or less was considered significant. 
Bland-Altman plots were used to detect bias and 95% limits 
of agreement between different ultrasound measurements. 
Results
The study screened 26 and enrolled 14 patients with OSA 
[AHI 19.6 (10.7) × hour-1] (Figure 7). The patients were 
middle-aged, overweight, with more men included. During 
ES, first sensation of the current was noted at 4.4 (1.5) mA, 
while contraction of the muscles was achieved at a level of 
10.9 (1.1) mA (Table 1). 
The mean quality of the ultrasound scans was scored as 
acceptable or good with 1.5 (0.5) points. The tongue base in 
the mid-sagittal plane (ΔDsagittal) increased by +12.2% (4.0%) 
with stimulation (Figure 8; P<0.001). The widest diameter 
in the sagittal plane increased similarly by +12.9% (5.2%) 
during stimulation (Figure 9; P<0.001; Table 2). 
In the coronal plane, ΔDcoronal increased by +12.3% (4.6%) 
with stimulation, while ΔAcoronal increased by +18.9% (3.0%) 
(P<0.001, respectively; Table 2; Figures 10,11). 
Although similar changes were recorded in the different 
planes and parameters, there was no significant correlation 
between them (Table 3). 
A Bland-Altman plot was generated to demonstrate the 
bias between the measurements in two planes (mid-sagittal 
and coronal diameters). The bias for ΔD in both planes was 
small [1×10-3 (0.056) cm] and the 95% limits of agreement 
reached from ‒0.109 to 0.111 cm (Figure 12).
There was a negative correlation between age and ΔA 
(coronal plane, r= ‒0.6, P=0.03; Table 4).
Figure 5 The tongue diameter and cross-sectional area in coronal plane with and without stimulation. (A) The position of the probe in the 
coronal plane. (B) In OFF-mode, illustrating the measured tongue base thickness with the double-arrowed red arrow (D1) and (C) in ON-
mode, showing (D2). (D) In OFF-mode, illustrating the measured cross-sectional area (A1) of the tongue thickness (red outline) and (E) in 
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Figure 6 Different ultrasound pictures of the submental area, the positioning of the probe is shown on the right lower coroner of each 
picture, they were classified according to semi-quantitative score. (A) and (B) are scored as ‘0’ due to inaccurate positioning of the probe 
(not centralized), improper view not showing the required structures, (C) and (D) are scored as ‘1’, as they hardly show the lower margins. 
(E) and (F) are scored as ‘2’, with good quality, unblurred vision showing the required structures adequately with proper positioning of the 
probe.
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Discussion
In this study, we found that on analysis of the mid-sagittal 
and coronal ultrasound images of the submental area in 
14 awake seated OSA patients, the tongue base thickness 
and CSA were significantly increased during the use of the 
transcutaneous ES. There was small bias for ΔD in both 
planes (95% limits of agreement: −0.109 to 0.111 cm). 
Contraction is best detected in the CSA of the tongue base 
in the coronal plane. Thus, the contraction of the upper 
airway dilator muscles in direct response to transcutaneous 
ES can be visualised using ultrasound.
In this context, reproducible measurements of the 
contraction of the tongue-ground muscles in the mid-
sagittal and coronal planes indicate a thickening of the 
muscles of about 10% (ΔD) (35). Considering the CSA of 
Patients recruited to the main shudy, 





Acceptable and good quality
(‘1’/‘2’) n=14 included
Offine recording of measurements
calculation of ΔD sagittal/coronal and ΔA 
analysis n=14
Ultrasound scans in mid sagittal and coronal plans duning
ON/OFF stimulation
All ultrasound images screened based on semi-qualitative quality score (0–2) n=26 
0= poor, 1= acceptable and 2= good
Figure 7 Flowchart showing the trial procedure steps. 
Table 1 Patients characteristics, reported as mean (SD), gender 
reported in numbers
Parameter (n=14) Mean ± SD
Sex (male/female) 8/6
Age (year) 57.6 (9.8)
Weight (kg) 87.4 (11.8)




Neck circumference (cm) 39.1 (4.0)
ESS (points) 9.6 (5.0)
AHI (event × hour
-1
) 19.6 (10.7)
Electrical current (mA) 10.9 (1.1)
ESS, Epworth Sleepiness Scale score. AHI, Apnea-Hypopnea Index.
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a muscle with a round model, any contraction leading to 
an increased diameter of +10% results in an increase of the 
CSA of about 21% (CSA = π * r
2 ) (35), and this is consistent 
with the observations of increased dimensions in the coronal 
plane (ΔAcoronal). The quality of the measurements depends 
on the individual anatomy, with a large neck circumference 
making it difficult to position the probe. However, once 
a good view is achieved, measurements of upper airway 
dilator muscle contraction can be accurately recorded.
Clinical significance
Previous studies have shown the importance of using 
different imaging methods (MRI, DISE and ultrasound) 
in visualisation of the pharynx, the tongue and the upper 
airway dilator muscles in OSA (38,41,42) evaluating the 
response of different muscle groups to ES, typically applied 
via HNS (43), but also non-invasively (30,35,36). In the 
current study, we demonstrated the use of ultrasound to 
detect muscle contraction in response to the electrical 
current delivered transcutaneously in awake patients with 
OSA. Although ultrasound imaging is non-invasive and 
allows good visualisation of the pharyngeal structures, 
standardisation of the technique is challenging. Posture, 
mouth position (open/closed), wake state, activity (talking/
quiet), probe positioning and movement artefacts can make 
accurate recordings difficult, as indicated by the excluded 
screened patients. However, we have shown reproducible 
results indicating the contraction of the upper airway 
dilator muscles in different planes, indicating that there 
is little difference in the mid-sagittal and coronal planes. 
Similarly, the percentual change in the mid-line diameter 
or the largest diameter in the sagittal plane indicates that 
both can be chosen for analysis, as long as comparisons are 
made with the correct reference. Our group has previously 
used ultrasound scans with similar findings, describing an 
increase in the distance from skin-to-tongue surface of 
10.0% (2.8%) on the sagittal view and 9.4% (3.7%) on the 
coronal view (35). 
Hofauer et al., used sonography to evaluate tongue 
motions in OSA patients who were using HNS. The tongue 
was scanned in four planes and, the horizontal and sagittal 
Sagittal diameter
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Figure 8  Box and whisker plot illustrating the recorded 
measurements of tongue base in the sagittal plane, midline 
(ΔDsagittal); OFF-mode (black box, left), ON-mode (grey box, 































Figure 9 Box and whisker plots chart illustrating the widest 
diameter in mid-sagittal plane, OFF-mode (black box, left), ON-
mode (grey box, right). ***, P<0.001.
Table 2 Mean (SD) of the measurements recorded in the two planes with electrical stimulation on and off 
Off On Δ change % change P value
Sagittal diameter, midline (cm) 1.41 (0.37) 1.58 (0.40) 0.17 (0.07) 12.2 (4.0) <0.001
Sagittal diameter,  widest (cm) 1.64 (0.37) 1.85 (0.42) 0.21 (0.09) 12.9 (5.3) <0.001
Plane B, coronal midline diameter (cm) 1.40 (0.28) 1.57 (0.29) 0.17 (0.04) 12.3 (4.6) <0.001
Plane B, Coronal CSA (cm
2
) 2.60 (0.63) 3.10 (0.77) 0.49 (0.16) 18.9 (3.0) <0.001
CSA, cross sectional area (reported in cm
2
), other parameters reported in cm and percent (%).
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planes were found to be preferable to the other investigated 
planes. Tongue motion was evident on the right (implanted) 
side in 75% in the horizontal plane (44). In our study, we 
detected motion during muscle contraction in 80%.
Kwan et al., compared ultrasound with magnetic 
resonance imaging to assess the sagittal measurements 
of the tongue movement during respiration in twenty-
one participants with and without OSA. There was 
an agreement between the two imaging methods with 
respect to the anteroposterior tongue motion during 
inspiration. Ultrasound measurements of the posterior 
tongue displacement were 0.24±0.64 mm greater than MRI 
measurements (95% limits of agreement: 1.03 to ‒1.49). 
The study concluded that ultrasound was a suitable method 
for measuring tongue movements (45). 
In an earlier study, Liu et al measured the lateral para-
pharyngeal wall thickness using ultrasound in fifty-
eight patients with OSA who had an AHI ≥10× hour–1 
and eighteen patients with an AHI <10× hour-1. The 
sonographic measurements correlated well when compared 
to magnetic resonance imaging in 15 patients out of the 
entire cohort (46).
Schwab et al., used computer tomography (CT) imaging 
during wakefulness in seven patients who responded to 
HNS and compared it to six non-responders. The patients 
had baseline scans without HNS, followed by repeat 
scans with HNS. In the baseline scan it was found that 
responders to HNS had a smaller soft palate volume and, 
with stimulation, they had a greater tongue displacement 
anteriorly, an increased retroglossal airway size, as well 
as a greater shortening of the mandible-hyoid distance. 
It was concluded that these findings can be considered as 
predictors of response to upper airway stimulation. (47). 
In our study, anterior tongue displacement was reliably 
observed. Despite difficulty of soft palate volume 
assessment by ultrasound, further studies are needed to 
assess the retroglossal airway size and the mandible-hyoid 
distance (48-50) with observation of changes in response 
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Figure 10 Box-whisker plots illustrating the coronal diameter; 



























OFF            ON
***
Figure 11 Box-whisker plots chart illustrating the coronal cross-
sectional area (CSA); OFF (black box, left) and ON (grey box, 
right). ***, P<0.001.  
Table 3 Pearson correlation analysis; % change
Parameters (change, %) R P
sagittal midline vs. coronal midline diameter 0.391 0.17
sagittal midline diameter vs. coronal CSA 0.295 0.31
























Figure 12 Bland-Altman plots for ΔD sagittal vs. coronal.
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Limitations 
This was a small physiological sub-study on the feasibility 
of a novel approach to assess upper airway muscle dilator 
response to transcutaneous ES. Although the sample size 
was small, reproducible measurements were obtained 
in multiple planes by the investigators. The ultrasound 
settings, particularly quality of tissue penetration of the 
picture varied amongst patients due to neck circumference 
and bulky soft tissue, as well as the anatomical relief 
allowing the placement of the probe in the right position. A 
previous lack of standardisation regarding recommendations 
about positioning and pressure of the applied probe may 
have further contributed to variability in the measurements. 
And thus, 12 (46%) out of 26 patients were excluded during 
the screening process (semi-quantitative score) due to low 
quality of their ultrasound images. Lastly, the patches used 
for transcutaneous ES interfered with the placement of the 
ultrasound probe and this emphasises the importance of an 
experienced investigator to record reliable measurements 
when assessing patients. Future studies could compare this 
method on a larger sample size and test different positions 
and investigators, as well as standardisation approaches. 
Furthermore, it would be useful to understand whether 
the observed effects of ES on the upper airway dilator 
muscles in the seated posture can be translated to the supine 
position, as this may be more relevant to the asleep patients. 
However, none of these confounders negate the relevance 
of having a ubiquitous tool available at the bedside when 
screening for responders to ES prior to engaging them for 
further assessments.
Conclusions
Ultrasound can visualise the upper airway dilator muscles 
in OSA patients and may serve to identify responders to ES 
to treat OSA, like HNS and TESLA. It has the advantage 
of being non-invasive and is widely available at the bedside. 
Despite limitations when using ultrasound due to qualitative 
pictures, contraction caused by transcutaneous ES can be 
determined by measuring the sagittal and coronal diameters 
of the tongue base. In future studies, it would be useful to 
combine the non-invasive ultrasound approach with other 
techniques, such as DISE and MRI, to validate the approach 
when assessing patients with OSA for novel treatment trials.
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